By
Sam Wightwick (Drug Target Review)2025-11-04T09:16:07
A newly developed peptide, WRPRFa, is giving scientists a clearer view of how the acid-sensing ion channel (ASIC3) drives pain signalling.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2024-02-06T08:57:06
Sponsored by bit.bio
2023-11-20T13:43:43
Sponsored by Merck
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2023-06-13T13:30:40
Sponsored by NanoTemper Technologies
2025-04-22T14:58:00
Sponsored by Takara Bio USA
Site powered by Webvision Cloud